Algert Global’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Algert Global’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,740	Closed	-$61K	–	453
2019 Q3	$61K	Buy	+14,740	New	+$53.2K	0.02%	340
2018 Q1	–	Sell	-77,985	Closed	-$281K	–	389
2017 Q4	$281K	Buy	77,985 +3,540	+5%	+$13.4K	0.07%	262
2017 Q3	$294K	Buy	74,445 +1,110	+2%	+$5.1K	0.07%	261
2017 Q2	$374K	Hold	73,335	–	–	0.11%	231
2017 Q1	$506K	Buy	73,335 +6,540	+10%	+$51.1K	0.14%	231
2016 Q4	$625K	Buy	66,795 +11,646	+21%	+$105K	0.18%	211
2016 Q3	$539K	Buy	+55,149	New	+$744K	0.16%	232

Other funds holding AGTC

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Algert Global's AGTC Position: Q4 2019 in Review

Algert Global sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2019, closing a stake of 14,740 shares — an estimated $61K sold.

Algert Global first reported a position in AGTC in Q3 2016 and held it in 7 quarters. The position peaked at $625K in Q4 2016. 52 funds tracked by Wall St. Rank hold AGTC as of Q4 2019.

Algert Global reported no remaining Applied Genetic Technologies Corporation position as of Q4 2019 after selling out during the quarter.
Algert Global sold 14,740 Applied Genetic Technologies Corporation shares in Q4 2019, an estimated $61K.
Algert Global first reported a position in Applied Genetic Technologies Corporation in Q3 2016 and held it in 7 quarters.
Algert Global's Applied Genetic Technologies Corporation position peaked at $625K in Q4 2016.
52 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2019.

Based on Algert Global's 13F filing for Q4 2019, filed 18 Feb 2020.